ABSTRACT
Non-rheumatic myocarditis occurs in therapeutic and cardiological practice both at prehospital and hospital stages. Diagnosis of this myocarditis at early stages is difficult. The course and outcome of this disease and its present-day treatment are outlined to help clinical and cardiological practitioners.
Subject(s)
Ambulatory Care , Cardiology , Myocarditis , Ambulatory Care/methods , Ambulatory Care/standards , Cardiology/methods , Cardiology/standards , Diagnosis, Differential , Early Diagnosis , Humans , Myocarditis/classification , Myocarditis/diagnosis , Myocarditis/etiologySubject(s)
Calcium Channel Blockers/therapeutic use , Hypertension/drug therapy , Stroke/prevention & control , Blood Pressure/drug effects , Humans , Hypertension/complications , Hypertension/physiopathology , Incidence , Russia/epidemiology , Stroke/epidemiology , Stroke/etiology , Treatment OutcomeSubject(s)
Adrenergic beta-Antagonists/therapeutic use , Calcium Channel Blockers/therapeutic use , Hypertrophy, Left Ventricular , Practice Patterns, Physicians' , Adrenergic beta-Antagonists/administration & dosage , Angiocardiography , Calcium Channel Blockers/administration & dosage , Coronary Circulation/drug effects , Diagnosis, Differential , Electrocardiography , Hemodynamics/drug effects , Humans , Hypertrophy, Left Ventricular/complications , Hypertrophy, Left Ventricular/diagnosis , Hypertrophy, Left Ventricular/drug therapySubject(s)
Endocarditis, Bacterial/diagnosis , Endocarditis, Bacterial/physiopathology , Fever/etiology , Outpatients , Splenomegaly/etiology , Acute Disease , Adult , Aged , Body Temperature/physiology , Diagnosis, Differential , Echocardiography , Electrocardiography , Fever/diagnosis , Fever/physiopathology , Heart Auscultation , Hematologic Tests , Humans , Middle Aged , Splenomegaly/diagnostic imaging , Time FactorsABSTRACT
Nebivolol was given to 30 hypertensive postmenopausal women as monotherapy (5-10 mg/day) or in combination with hydrochlorothiazide. Clinical effect was achieved in 76.6 and 86.7% of women on mono- and combination therapy, respectively. Hypotensive effect was confirmed by 24-hour blood pressure monitoring. Blood pressure lowering was associated with decrease of total peripheral resistance and regression of left ventricular hypertrophy. Nebivolol appeared to be metabolically neutral and only sporadic adverse effects were registered.
Subject(s)
Antihypertensive Agents/therapeutic use , Benzopyrans/therapeutic use , Ethanolamines/therapeutic use , Hypertension/drug therapy , Postmenopause/physiology , Analysis of Variance , Antihypertensive Agents/adverse effects , Benzopyrans/adverse effects , Drug Therapy, Combination , Ethanolamines/adverse effects , Female , Humans , Hydrochlorothiazide/therapeutic use , Hypertension/physiopathology , Middle Aged , Nebivolol , Treatment OutcomeABSTRACT
The cephalosporin antibiotic zinnat was given to 171 outpatients with bronchopulmonary infections. Pneumonia patients received 500 mg, patients with acute bronchitis or exacerbation of chronic bronchitis 250 mg twice a day. The recovery was registered in 97.7, 98.8 and 91.8% of patients, respectively. The drug proved effective, low-toxic, convenient in use. Wide-spectrum action, significant activity against both gram-positive and gram-negative pathogens make zinnat a promising drug for outpatient treatment of bronchopulmonary infections.
